Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 358   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     
This article has been cited by
1WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
Gaber El-Saber Batiha,Dr. Ali I. Al-Gareeb,Safaa Qusti,Eida M. Alshammari,Damilare Rotimi,Oluyomi Stephen Adeyemi,Hayder M. Al-kuraishy
Scientific African.2021;()e01084
[DOI]
2The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Marwa S. Al-Niemi,Reem M. Aljowaie,Saeedah Musaed Almutairi,Athanasios Alexiou,Gaber El-Saber Batiha
Inflammation.2022;45(4)1651
[DOI]
3Apelin controls emotional behavior in age- and metabolic state-dependent manner
S. Bullich,P. de Souto Barreto,A. Dortignac,L. He,C. Dray,P. Valet,BP Guiard
Psychoneuroendocrinology.2022;140(4)105711
[DOI]
4Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Gaber El-Saber Batiha,Hayder M. Al-kuraishy,Thabat J. Al-Maiahy,Ali K. Al-Buhadily,Hebatallah M. Saad,Ali I. Al-Gareeb,Jesus Simal-Gandara
Diabetology & Metabolic Syndrome.2022;14(1)105711
[DOI]
5Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Amany Magdy Beshbishy,Victor B. Oti,Diaa E. Hussein,Ibrahim F. Rehan,Oluyomi S. Adeyemi,Nallely Rivero-Perez,Adrian Zaragoza-Bastida,Muhammad Ajmal Shah,Khaled Abouelezz,Helal F. Hetta,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Public Health.2021;9(1)105711
[DOI]
6Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Hayder M. Al-Kuraishy,Ali I. Al-Gareeb,Hany Akeel Al-hussaniy,Nasser A. Hadi Al-Harcan,Athanasios Alexiou,Gaber El-Saber Batiha
International Immunopharmacology.2022;104(1)108516
[DOI]
7Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
Bao Sun,Zhiying Luo,Jiecan Zhou
Cardiovascular Diabetology.2021;20(1)108516
[DOI]
8High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Luay Alkazmi,Ola A. Habotta,Gaber El-Saber Batiha
Inflammopharmacology.2022;30(3)811
[DOI]
9Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19
Shahenda Mahgoub,Samar S. Fatahala,Amira I. Sayed,Hanaa B. Atya,Mohamed F. El-Shehry,Hala Afifi,Samir M. Awad,Rania H. Abd El-Hameed,Heba Taha
Bioorganic Chemistry.2022;128(3)106092
[DOI]
10COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Susana G. Guerreiro,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Cardiovascular Medicine.2021;8(3)106092
[DOI]
11COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Medicine.2021;8(3)106092
[DOI]
12Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Naeem Qusty,Athanasios Alexiou,Gaber El-Saber Batiha
Current Molecular Pharmacology.2022;15(4)683
[DOI]
  Feedback 
  Subscribe 




Most popular articles
Join us as a reviewer
Email alerts
Recommend this journal